Artiva Biotherapeutics, Inc. (ARTV) EBITDA Margin (2023 - 2024)
Artiva Biotherapeutics' EBITDA Margin came in at -25837.05% for FY2024, down 25752.24 percentage points from -84.81% in FY2023.
Powered by 
Analysis
Artiva Biotherapeutics, Inc. (ARTV) EBITDA Margin (2023 - 2024) Analysis & Trends
- Per Business Quant, earlier years put EBITDA Margin at -84.81% in FY2023.
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | -5,539.84% |
| Dec 31, 2023 | -484.09% |
| Sep 30, 2023 | 42.64% |
| Jun 30, 2023 | -323.82% |
API Access
Artiva Biotherapeutics, Inc. EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ARTV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ARTV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ARTV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();